USEC Inc. (NYSE:USU) closed up 143.89% today after news of its 8-K filing with the Securities and Exchange Commission (SEC) regarding new funding, of $2.5 million, from the US Department of Energy (DOE). The funding comes following an amendment to an agreement with a research lab operator for further research on American Centrifuge technology. USEC Inc. (NYSE:USU) stock performance was 143.89% in last session and finished the day at $7.39. Traded volume was 11.67million shares in the last session and the average volume of the stock remained 92.64K shares. The beta of the stock remained 3.00. USEC Inc. (NYSE:USU) insider ownership is 2.70%.
Voxeljet A.G. (ADR) (NYSE:VJET) saw short interest rise 10.3% to 1.74 million shares, with a days to cover number of 7. Since coming public at $19 in mid-October the share price is down about 36%. Year to date, shares are down nearly 58%, but rose about 1% in the two-week period to June 13. The stock closed at $18.40 last night in a post-IPO range of $12.85 to $70.00. Voxeljet AG (ADR) (NYSE:VJET) rose 23.69 percent to $25.90 Tuesday on volume of 5.59million shares. The intra-day range of the stock was $21.55 to $27.41. Voxeljet AG (ADR) (NYSE:VJET) has a market capitalization of $404.04million.
Arista Networks Inc (NASDAQ:ANET) has received a consensus rating of “Buy” from the eighteen ratings firms that are covering the company, Analyst Ratings News reports. Six equities research analysts have rated the stock with a hold recommendation, eleven have given a buy recommendation and one has given a strong buy recommendation to the company. Arista Networks Inc (NYSE:ANET)’s stock on July 01, 2014 reported a increase of 21.81% to the closing price of $76.00. Its fifty two weeks range is $55.00 -$76.83. The total market capitalization recorded $4.85billion. The overall volume in the last trading session was 1.66million shares. In its share capital, ANET has 63.58million outstanding shares.
Amicus Therapeutics Inc. (NASDAQ:FOLD) provided updates and a final analysis plan for its second phase III study (Study 012) on migalastat HCl as a monotherapy in Fabry patients with amenable mutations. Amicus’ shares jumped over 10% following the announcement. On Tuesday, shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) advanced 19.46% to close the day at $3.99. Company return on investment (ROI) is -100.50% and its monthly performance is recorded as 62.20%. Amicus Therapeutics, Inc. (NASDAQ:FOLD) quarterly revenue growth is 95.59%.
EveryWare Global Inc. (NASDAQ:EVRY) must negotiate an additional waiver from its lenders, led by Deutsche Bank , or raise new debt or equity financing in order to keep its lenders from taking immediate action to collect debt owed before June 30. Everyware Global Inc (NASDAQ:EVRY) stock performance was 17.69% in last session and finished the day at $1.53. Traded volume was 351,815.00million shares in the last session and the average volume of the stock remained 297.35K shares. Everyware Global Inc (NASDAQ:EVRY) insider ownership is 0.40%.